Dose confirmation
Showing 1 - 25 of >10,000
Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- BI 764532
- Topotecan
- (no location specified)
Aug 7, 2023
Influenza, Human Trial (Flu mRNA, Control 1, Control 2)
Not yet recruiting
- Influenza, Human
- Flu mRNA
- +2 more
- (no location specified)
Apr 21, 2023
Hemophilia B Trial in Los Angeles (verbrinacogene setparvovec)
Recruiting
- Hemophilia B
- verbrinacogene setparvovec
-
Los Angeles, CaliforniaChildren's Hospital of Los Angeles
Jan 7, 2022
Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
- Obexelimab
- Placebo
- (no location specified)
Mar 24, 2023
Advanced Solid Tumor Trial in China (IO-108, IO-108 + pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- IO-108
- IO-108 + pembrolizumab
-
Changsha, Hunan, China
- +3 more
Aug 18, 2022
Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- NisinZ® P
- Surgery (non-interventional, standard of care)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 18, 2023
MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)
Completed
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia (AML)
-
Chicago, Illinois
- +5 more
Mar 15, 2022
Coronavirus, Covid19, SARS-CoV-2 Trial in Panama city, Lima (CVnCoV 6 µg, CVnCoV 12 µg, Hepatitis A vaccine)
Completed
- Coronavirus
- +3 more
- CVnCoV 6 μg
- +4 more
-
Panama city, Panama
- +1 more
Mar 9, 2022
Hemophilia B Trial in United States (AAV5-hFIXco-Padua (AMT-061))
Active, not recruiting
- Hemophilia B
- AAV5-hFIXco-Padua (AMT-061)
-
Los Angeles, California
- +3 more
May 17, 2022
BK Virus Infection, Nephropathy, Kidney Transplantation Trial in Australia, Japan, Korea, Republic of (Brincidofovir)
Not yet recruiting
- BK Virus Infection
- +2 more
-
Adelaide, Australia
- +9 more
Aug 22, 2022
NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)
Recruiting
- Non-Small Cell Lung Cancer
- BNT116
- +2 more
-
Baltimore, Maryland
- +14 more
Dec 19, 2022
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level
Not yet recruiting
- Limb Girdle Muscular Dystrophy
- +8 more
- LION-101 dose level 1
- +2 more
- (no location specified)
Feb 17, 2022
Metastatic Ovarian Cancer, Triple Negative Breast Cancer Trial in Re?ovot (Nerofe is a first in class derivative of a human
Withdrawn
- Metastatic Ovarian Cancer
- Triple Negative Breast Cancer
- Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties.
-
Reẖovot, IsraelOncologic Institue, Kaplan
Oct 18, 2021
Zika Virus Trial in Puerto Rico, United States (mRNA-1893, Placebo)
Active, not recruiting
- Zika Virus
- mRNA-1893
- Placebo
-
Sioux City, Iowa
- +10 more
Aug 31, 2022
Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)
Terminated
- Influenza, Human
- NanoFlu (Quad-NIV)
- +5 more
-
Hollywood, Florida
- +13 more
Nov 3, 2022
Multiple Myeloma, Relapse Multiple Myeloma Trial in Ramat Gan (CAR-BCMA)
Recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
- CAR-BCMA
-
Ramat Gan, IsraelChaim Sheba Medical Center, Tel Hashomer
Feb 7, 2022
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
Sinusitis, Acute Trial in Cohoes (Amoxicillin 875 mg, Placebo (lactase))
Terminated
- Sinusitis, Acute
- Amoxicillin 875 mg
- Placebo (lactase)
-
Cohoes, New YorkAlbany Medical Center Internal Medicine and Pediatrics
Jul 19, 2021
Metastatic Breast Cancer Trial in Bulgaria, Russian Federation, United Kingdom (Eribulin mesylate, Capecitabine)
Completed
- Metastatic Breast Cancer
- Eribulin mesylate
- Capecitabine
-
Pleven, Bulgaria
- +9 more
Jan 6, 2021
Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose
Not yet recruiting
- Influenza, Human
- Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
- +3 more
-
Tempe, Arizona
- +44 more
Aug 16, 2022
Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)
Recruiting
- Melanoma (Skin)
- Non-Small-Cell Lung Carcinoma
- GAd-PEV
- MVA-PEV
-
Charleroi, Belgium
- +6 more
Feb 23, 2022
Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,
Recruiting
- Lymphoma, Large B-Cell, Diffuse (DLBCL)
- Zilovertamab Vedotin
- +6 more
-
Victoria, British Columbia, Canada
- +19 more
Jan 19, 2023
Gastro-Enteropancreatic Neuroendocrine Tumor Trial in Austria, Denmark, United States (Satoreotide trizoxetan 5-20µg,
Completed
- Gastro-Enteropancreatic Neuroendocrine Tumor
- Satoreotide trizoxetan 5-20μg
- Satoreotide trizoxetan 30-45μg
-
Los Angeles, California
- +4 more
Jan 8, 2021